SCHEMBL30801787

SCHEMBL30801787

O=C1[C@H]2CNCCN2CCN1c1ncc(-c2cccc(Cl)c2)s1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 2/20 0.37
CHEK1 O14757 4/20 0.36
HTR1A P08908 2/20 0.35
HTR2A P28223 2/20 0.35
HTR2C P28335 2/20 0.35
HTR7 P34969 2/20 0.35
HTR2B P41595 2/20 0.35
HTR3A P46098 2/20 0.35
HTR6 P50406 2/20 0.35
HTR5A P47898 1/20 0.35
DRD2 P14416 1/20 0.34
CDK2AP1 O14519 1/20 0.33
HTR1D P28221 1/20 0.33
HTR1B P28222 1/20 0.33
ALDH1A1 P00352 2/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30801827 1.00 USP30 (0.37) USP30CHEK1HTR1AHTR2AHTR2C
SCHEMBL30801791 0.90 USP30 (0.45) USP30CHEK1ALDH1A1MEN1LMNA
SCHEMBL30801881 0.90 USP30 (0.45) USP30CHEK1ALDH1A1MEN1LMNA
SCHEMBL30801856 0.87 USP30 (0.42) USP30CHEK1DRD2ALDH1A1HPGD
SCHEMBL30801732 0.87 USP30 (0.42) USP30CHEK1DRD2ALDH1A1HPGD
SCHEMBL30801894 0.85 HDAC3 (0.36) USP30CHEK1ALDH1A1SMN1; SMN2
SCHEMBL30801821 0.83 KDR (0.38) USP30
SCHEMBL30801831 0.83 KDR (0.38) USP30
SCHEMBL30801777 0.82 HTR2C (0.38) HTR1AHTR2AHTR2CHTR7HTR2B
SCHEMBL30801874 0.82 HTR2C (0.38) HTR1AHTR2AHTR2CHTR7HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3793997-B1 FUSED BICYCLIC COMPOUNDS USEFUL AS UBIQUITIN-SPECIFIC PEPTIDASE 30 INHIBITORS FORMA THERAPEUTICS INC (US) 2024-03-13 EP claimed